Abstract | Osteoarthritis (OA) is the most common joint disorder. The Osteoarthritis Initiative (OAI) is a multicentre, longitudinal, prospective observational cohort study of knee OA that aims to provide publicly accessible clinical datasets, images and biospecimens, to enable researchers to investigate factors that influence the onset and development of OA, and evaluate biomarkers that predict and track the course of the disease. In this Perspectives, we describe the rationale and design of the OAI and its cohort, discuss imaging protocols and summarize image analyses completed to date. We include descriptive analyses of publicly available longitudinal (2-year) data of changes in cartilage thickness in a core sample of 600 knees from 590 participants in the OAI progression subcohort. Furthermore, we describe published methodological and applied imaging research that has emerged from OAI pilot studies and OAI data releases, and how these studies might contribute to clinical development of biomarkers for assessing the efficacy of intervention trials.
Introduction
The Osteoarthritis Initiative (OAI) 1 is an ongoing multicentre observational cohort study of knee osteoarthritis (OA), jointly sponsored by the NIH and the pharmaceutical industry. Targeted at identifying sensitive imaging and biochemical biomarkers for the onset and progression of knee OA, and for use in evaluating the effectiveness of disease-modifying therapy, the OAI has enrolled almost 4,800 participants with, or at risk of developing, symptomatic knee OA. To date, clinical, radiographic, and MRI data from baseline and 4 years of annual followup have been made publicly available to the research community. 1 Publications using OAI data have examined the precision, sensitivity to change, and correlation with clinical covariates of imaging outcomes, including radiographic joint-space width (JSW), cartilage thickness, cartilage composition, meniscus morphology, and muscle cross-sectional areas. In this article and the accompanying supple mentary information online, we provide a comprehensive overview of the ongoing achievements of the OAI.
Rationale for and design of the OAI
OA is one of the most common diseases of mankind and the most common synovial joint disorder. Owing to its high prevalence and impact on physical function, OA is one of the most frequent causes of disability in developed nations. The number of Americans with clinical (symptomatic) OA (27 million in 2005 ) is expected to increase dramatically as the population ages. In 2004, half a million primary knee replacement procedures were performed for OA in the USA, and by 2030 that number is projected to grow to 3.5 million. Therefore, a better understanding of the aetiology and risk factors of the disease, and validated imaging biomarkers that can be used to test the efficacy of novel disease-modifying treatments that postpone or prevent the need for joint replacement, are urgently needed. Current drug therapies for OA target symptoms but not the cause of the disease, and no treatments currently approved by regulatory agencies are able to inhibit the progression of structural changes that underlie symptoms. Clinical testing of new pharmacological and nonpharmacological therapies is complicated by the slow develop ment and highly variable manifestation of OA.
Radiography has long been the primary means of assessing structural change, but is limited by low sensitivity to disease progression and by inability to image nonosseous pathology. Whereas OA has traditionally been considered a disease of articular cartilage, its pathogenesis is now accepted to encompass all articular tissues. Essential steps to enable progress in combating OA include a better understanding of the risk factors for OA, a comprehensive characterization of its natural history in all articular tissues, and the development of sensitive biomarkers for testing effectiveness of treatments. For these aims, longitudinal state-ofthe-art imaging studies are needed in large, well-characterized populations of persons with, or at risk of developing, OA over a period of time in which clinical change can be clearly defined.
To address these challenges, the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) organized a series of meetings and workshops in 1999, to plan the OAI. 1 The outcome was the creation of a multicentre, longitudinal, prospective observational cohort study of knee OA that also includes imaging of hip and hand OA. The overarching goal is to provide publicly accessible clinical datasets, radiographs, magnetic resonance imaging (MRI) data and biospecimens to enable researchers worldwide to describe the full natural history of OA, investigate factors that influence disease onset and development, and evaluate biomarkers that pre dict and track its course. Open access to the data and images has the potential to increase the generation of new knowledge from the study and to accelerate our understanding of the disease through an international collabo rative effort. The OAI differs from other large-cohort OA studies in being specifically designed to contribute to the clinical development and qualification of imaging, biochemical and genetic OA biomarkers. It is the only such study to use standardized 3 Tesla MRI (3T-MRI) scanners and protocols, and to make all data available for public use. 3T-MRI rather than 1.5T-MRI was selected on the basis of greater signal-to-noise and contrast-to-noise ratios that can be achieved using the greater field strength provided by the former, which potentially translates into greater precision and sensitivity to change. Furthermore, a comprehensive MRI protocol was implemented, 2 to permit determination of a wide variety of quantitative and semiquantitative imaging biomarkers. This step was taken to enable exploration of the most promising markers in the contexts of predicting the onset of symptomatic knee OA, predict ing its (structural) progression, and predicting clinical outcomes.
OPINION
Almost 100 published papers have emerged to date from clinical and imaging data in the OAI cohort ( Table 1 ). The first original paper to use OAI pilot study data was published in 2006, with a sharp increase in the rate of publications in 2009 after the first large-scale data releases had become available. 21 abstracts from the OAI were presented at the World Congress of Osteoarthritis 2011 (18 with imaging data), and 37 in 2012 (27 with imaging data). Eventually, imaging data from the entire cohort is expected to be analyzed and published, but given the substantial amount of resources and funding required, this process will take some time; to date, images of only subsets of the OAI cohort have been studied.
To provide a comprehensive and systematic summary of literature that has emerged from OAI imaging data, we reviewed all original papers that used OAI (or OAI pilot study) images and that are listed on the OAI website, 1 excluding reviews, overviews, and study design papers. In addition, we performed a systematic search of the PubMed database in February 2012, using the key words "Osteoarthritis Initiative" and "OAI". Further literature was included during the revision in May 2012. To com ply with edi torial limits that apply to Perspectives articles, OAI imaging literature of clinical relevance is discussed in the main text, whereas more technically-oriented papers have been included in Supplementary  Tables 1-3 online.
The OAI cohort
Starting in 2002, the four OAI clinical centres (all located in the USA) enrolled approxi mately 4,800 male or female participants of all ethnicities, aged 45-79 years, with, or at high risk of, knee OA incidence or progression (Box 1). The sample size was based on the statistical power needed to determine whether biomarkers predict relatively uncommon endpoints, such as the onset (incidence) of symptomatic knee OA or joint replacement, and to compare correlations of changes in different bio markers over time with continuous measures of progression of symptoms and/or joint-space loss and cartilage loss. Such studies can be performed using nested case-control or case-cohort analytical designs, in which subsets of knees with and without clinical or structural outcomes of interest are compared. The overall sample size is also large enough to accommodate studies of other informative subsets of subjects (that is, those with unilateral pain or unilateral radiographic OA) while still having adequate numbers for analysis.
Exclusion criteria for the OAI cohort were bilateral end-stage knee OA-knee arthroplasty or bilateral radiographic KellgrenLawrence grade (KLG) 4, the maximum on the 0-4 KLG scale-and inflammatory arthritis. Located at the University of Maryland School of Medicine and the Johns Hopkins University (Baltimore, MD), the Ohio State University (Columbus, OH), the University of Pittsburgh (Pittsburgh, PA), and the Memorial Hospital of Rhode Island (Pawtucket, RI), the clinical centres have now followed the cohort for up to 8 years. Participants are assessed annually in examinations and interviews using both traditional outcome measures (radiography, joint pain, disability, joint replacement), and novel endpoints derived from MRI findings and biochemical biomarkers. At enrollment, participants were assigned to one of three subcohorts, representing the full spectrum of disease development and progression, Box 1 | OAI subcohort assignment at baseline Upon enrollment, participants in the OAI were assigned to one of three subcohorts. The subcohort distributions of KLGs provided in this Box reflect centralized readings that replace readings made at clinical centres at baseline during recruitment.* Progression subcohort (n = 1,390) Comprises individuals with prevalent symptomatic femorotibial OA in one or both knees; furthermore, in any knee with frequent pain (pain on most days of a month in the past year) definite femorotibial osteophytes were present in the same knee. KLG distribution: KLG0, n = 347; KLG1, n = 338; KLG2, n = 920; KLG3, n = 719; KLG4, n = 213; knees without reading results (for example, those with a prosthesis), n = 243.
Incidence subcohort (n = 3,284) Comprises individuals at risk of development of symptomatic femorotibial OA; patients had one or more of the following risk factors for knee OA: ■ frequent knee pain in a knee without radiographic OA ■ radiographic OA without frequent pain ■ infrequent knee pain ■ overweight for age and gender ■ history of knee injury/surgery ■ family history of knee replacement ■ Heberden's nodes ■ age 70-79 years Furthermore, in any knee with frequent pain, no radiographic femorotibial OA was present. KLG distribution: KLG0, n = 2,882; KLG1, n = 1,228; KLG2, n = 1,435; KLG3, n = 719; KLG4, n = 213; knees without reading results, n = 424.
Non-exposed reference cohort (n = 122) Individuals without OA (no symptoms in either knee, no radiographic femorotibial OA in either knee), and with no risk factors for knee OA. KLG distribution: KLG0, n = 213; KLG1, n = 23; KLG2, n = 4; knees without reading results, n = 4.
on the basis of a local (site) reading of the baseline knee radiograph and the presence of knee symptoms and risk factors for knee OA (Box 1).
The OAI MRI protocol
As mentioned above, the architects of the OAI opted to use 3T-MRI systems because of the advantages they offer over lower field-strength scanners in terms of signalto-noise and contrast-to-noise ratios, spatial resolution, and/or acquisition time. MRI scanners used by the OAI undergo monthly quality assurance testing (Supplementary Table 1 online). The OAI MRI protocol was designed to support a thorough clinical and research evaluation of the femorotibial and patellofemoral joints of both knees, to support as broad a range of existing and anticipated measurement methods for as many articular structures and features as possible (Figure 1 ), while keeping the total scan time within a range tolerated by most participants (60 min). 2 Because of the relative lack of experience with 3T-MRI systems, pilot testing of novel sequences was undertaken. 3 The core knee MRI protocol of the OAI requires 60 min of acquisition time 2 and was designed for assessment of both quantitative and qualitative measures of OA pathology (the OAI imaging protocol is outlined in Table 2 ).
Publicly available image data
Clinical data, joint and muscle imaging data, and readings or measurements from these OAI images are available online 1 and are summarized in Table 3 . Knee radiographs from the first five annual examinations for all participants for whom follow-up images are available have been read centrally for KLGs and individual radiographic features, and, for the majority, radiographic JSW has been measured quantitatively. MRIbased quantitative assessments of cartilage thickness change are also available; 2-year longitudinal data from a core sample of the progression subcohort (600 knees of 590 OAI participants) are summarized in Table 4 , which provides the mean change, and variability thereof, in different regions of the joint (according to the online data). The greatest rate of change was observed in the central part of the weight-bearing medial femoral condyle (-5.0% over 2 years) and in the external medial tibia (-5.1%); the greatest sensitivity to change (calculated as standardized response mean [SRM], which is mean change divided by the standard deviation of change across all knees) was observed in the total femorotibial compartment (-0.56), followed by the central medial femoro tibial compartment (-0.51). In other words, these regions have the most bene ficial ratio between magnitude of change and the variability of the change between par ticipants, and are thus the regions most 'sensitive' to change. Image analysis is ongoing in several large projects (funded, for example, by ancillary grants from the NIH) and more image analysis data will hence become publically available in the future.
Pilot and methodological studies
The MRI scanners at the four OAI centres are monitored using phantoms (which check consistency of images produced) to ensure that longitudinal measurements are not affected by scanner drift. Consistency in terms of MRI findings between the four OAI centres has been demonstrated, alongside good signal and geometric stability over the first 3 years' follow-up (Supplementary Table 1 
online).
OAI MRI pilot studies A pilot study was conducted to evaluate the test-retest precision of quantitative cartilage analysis, and its sensitivity to changes in cartilage thickness over 1 and 2 years, using images from different 3T-MRI sequences included in the OAI acquisition protocol. Performance metrics were compared between four groups conducting the image analysis, 3 and between different MRI contrasts-for example FLASH, which is T1-weighted, and double echo at steady state (DESS), which involves both T1-weighted and T2-weighted contrast-and have also been published in part by individual groups (Supplementary Table 1 online). The fourgroup comparison 3 concluded that cartilage morphology metrics, such as cartilage volume or thickness obtained using different image contrasts in the same knees had similar test-retest precision and were generally equivalent: data from different contrasts can therefore be combined. Given systematic differences in results from different analysis teams, it was concluded that data from different teams should not be pooled unless equivalence is demonstrated for the metric of interest in future cross-calibration studies. 3 In other papers, FLASH and DESS acquisitions obtained with different MRI knee coils (phased-array and quadrature coils) were compared and found to involve slight differences (offsets) in cartilage volume and thickness measures obtained. Two groups also reported longitudinal (2-year follow-up) results from OAI pilot studies (Supplementary Table 1 online) and concluded that FLASH and DESS were sensitive to change in cartilage volume and thickness seen in knee OA.
OAI methodological studies Several methodological comparisons have been made regarding quantitative radio graphic data generated by the OAI (Supple mentary Table 2 online). The findings emphasize, for example, the need to take radio-anatomic alignment of OAI fixed-flexion radiographs into account when analyzing change in JSW, and the need for central radiographic readings. Regard ing semiquantitative scoring of articular tissue pathology using MRI images, two existing systems-WORMS (whole organ MRI score) and BLOKS (Boston Leeds osteo arthritis knee score)-were applied to a sample of images of 113 knees with radiographic OA and at risk of progression, from the OAI cohort. Both methods were shown to be reliable cross-sectionally (Supplementary  Table 2 online). Longitudinally, BLOKS was found to be superior to WORMS for assessment of change in the meniscus, and WORMS was superior to BLOKS for scoring bone-marrow lesions (BMLs), in terms of predicting cartilage loss. 4 A new hybrid method (MOAKS; MRI OA knee score) was hence proposed with the aim of combining the advantages of each scoring system. 5 In assessing which sequence is better to detect such changes, more and larger focal cartilage defects and BMLs were detected with the intermediate-weighted fat-suppressed spin echo sequence than with DESS 6,7 (Figure 2, Supplementary Table 2 online).
Semi-automated segmentation algorithms for quantitative measurement of cartilage, bone, meniscus, and thigh muscles (Figure 3 ) have been assessed. These studies have used different image analysis approaches and have reported, in part, the level of agreement with manual segmentation and/or the level of inter-observer reliability (Figure 1,  Supplementary Table 2 online) .
The sensitivity to change of cartilage thick ness over 1 year in the medial femorotibial compartment was found to be similar between sagittal DESS, coronal multiplanar reconstructed DESS, and coronal FLASH in 80 knees (Figure 2) , with SRMs ranging from -0.34 to -0.38. 8 The three protocols were also highly intercorrelated crosssectionally (coefficient of correlation [r] ≥0.94); analysis of every second 0.7 mm DESS image provided similar sensitivity to change as analysis of every image. 8 Change in the medial weight-bearing femur substantially exceeded that in the posterior aspect of the femoral condyle, suggesting that structural progression is faster in (common ly) weight-bearing regions of the joint. 9 Measuring between-group differences using cartilage subregions (Figure 4) or atlases of cartilage thickness within anatomically defined cartilage plates has also been explored by several groups, alongside assessing whether such methods improve sensitivity to change (Supplementary Table 3 online). These studies generally identified the central subregion of the weight-bearing medial femoral cartilage plate as the region of interest with the greatest rate of cartilage loss and sensitivity to change (Figure 4 ).
First-release image analysis
Analyses of the first public release of OAI knee images-from 160 participants with symptomatic knee OA-showed that meniscal damage was common (79% medially, 39% laterally) and was associated with presence of BMLs in the same (medial or lateral) joint compartment. 10 BML and joint effusion scores (using BLOKS), but not synovitis, were independently associated with knee pain (using the Western Ontario and McMaster Universities Osteo arthritis Index; WOMAC), suggesting that pain in knee OA has more than one potential source. 11 14% of the participants had an anterior cruciate ligament (ACL) tear, and had more denuded areas (exposure of subchondral bone), meniscal damage, and BMLs than those without tears. 12 Furthermore, ACL tears were related to femoral notch stenosis. 13 1-year cartilage volume loss rates in symptomatic knees (reported using semi-automated segmentation of DESS) 14 and cartilage thick ness loss in all right knees of this sample (using manual segmentation of FLASH images) 15 were similar between both contrasts across the four femorotibial cartilage plates (Figure 5a) , with relatively modest SRMs (Figure 5b) . Use of fixed flexion radiography at an optimal fixed location (0.275) was more sensitive to change in JSW than assessing the point of minimal JSW, using automated software 16 ( Figure 5 ). No significant differences in cartilage thickness loss by sex, BMI, symptom status, or KLG were observed in this sample, 15 but SRMs were substantially greater in knees with denuded subchondral bone areas, 17 JSN (but not osteophytes), subchondral bone sclerosis, and low cartilage thickness at baseline, 18 suggesting that knees at advanced stages of structural joint disease have greater structural progression than those at earlier stages.
Large-release OAI imaging data
Cartilage thickness analysis An aim of the OAI is to relate cartilage thickness changes to radiographic disease status. In the non-exposed reference cohort of the OAI (Box 1), subregional cartilage thickness was similar to that in a large population-based cohort without OA. 19 A cross-sectional study in >1,000 par ticipants representing all KLGs reported significantly larger subchondral bone areas in OA than in reference cohort knees (~10% larger, P <0.01). 20 Compared with reference knees, cartilage thickness differences were greatest in the external medial tibia of OA knees with medial JSN, and in the external lateral tibia of those with lateral JSN. 20 Greater cartilage thickness than in healthy reference par ticipants was reported in the external central medial femur of knees with early radiographic OA (KLG ≤2), 20 and confirmed in the external weight-bearing medial (and lateral) femur in a study that compared knees with osteophytes (and without JSN) with contralateral knees without osteophytes or JSN, using a between-knee, withinperson design. 21 Although this combination of radiographic features was observed in only 1.3% of the 4,796 OAI participants, the OAI cohort size enables such analyses, which exclude confounding from betweenperson differences.
Denuded areas were present at early stages of radiographic OA (KLG1 and KLG2) and became more common (and larger) with increasing radiographic disease severity. 22 In 73 participants with medial Osteoarthritis Research Society International (OARSI) JSN grade 1-3 in one knee and a contralateral knee without JSN, medial JSN grades 1-3 were associated, respectively, with 5%, 18%, and 44% reductions in medial femoro tibial cartilage thickness. 23 Longitudinal (1-year) analysis of change in cartilage thickness in 719 knees with radiographic OA found a low rate of change in KLG2 knees (≤1%, SRM up to -0.22; not significantly different from 112 reference cohort knees), up to -2.5% (SRM up to -0.35) in KLG3, and up to -3.9% (SRM up to -0.51) in KLG4. 24 In the same sample, an extended ordered value approach (which ranks subregional femorotibial cartilage loss in the medial and lateral compartments *The greatest rate of change is observed in the central part of the weight-bearing medial femoral condyle and in the external medial tibia (see Figure 4 for cartilage regions); the greatest sensitivity to change (SRM) is observed in the total femorotibial compartment followed by the central medial femorotibial compartment. ‡ Obtained with a sagittal double echo steady state MRI sequence in a core sample of the OAI progression subcohort and available online. 1 § SRM calculated as mean change divided by standard deviation of the change across all knees. Abbreviations: OAI, Osteoarthritis Initiative; SRM, standardized response mean.
based on its magnitude, and computes averages across these ranks-or ordered values-rather than across specific locations) was superior in differentiating rates of progression between KLG3 and KLG2 knees (P = 5.4 × 10 -7
) to the region-based approach (P = 0.008) and radio graphy (P = 0.386). 25 Furthermore, in the same sample it was found that knees with frequent pain displayed greater rates of cartilage loss than those without pain, even after adjustment for or stratifying by KLG. 26 Using a betweenknee, within-person design, MRI-based cartilage loss rates were greater in knees with JSN than those without (both painful), 9 whereas radiographic JSW change did not differ between the knees, but was more variable in knees without JSN. 27 Radiographic JSN in hand radiographs from this cohort was associated with reduced knee cartilage thickness, and hand osteophytes with radiographic knee OA status, but neither was associated with structural progression in the knee. 28 Systemic susceptibility to OA, and possibly different mechanisms for osteophyte formation and cartilage thinning, are suggested by these findings. 28 Over 2 years, the SRM for cartilage thickness change in 346 OAI participants was modestly higher than over 1 year, 29 and the rate of change was not significantly different between the first and second year. 29 In summary, these data suggest that when MRI-based cartilage thickness outcomes are used as measures of progression, structural disease progression is more likey to occur in painful knees with advanced radiographic OA status than knees without pain and without radiographic JSN.
Cartilage lesions and composition
In asymptomatic, middle-aged incidence cohort participants, cartilage lesions (includ ing signal changes without focal loss) were found in 75%, meniscal lesions in 47%, and BMLs in 40% of knees studied, 30 with a similar prevalence of lesions reported in ◀ PERSPECTIVES the non-exposed reference cohort. 31 These lesions were more frequent in subjects with greater levels of physical activity, 30 greater BMI, 32 and ACL injuries. 33 Over 36 months, the incidence and progression of cartilage lesions (but not meniscus lesions) was greater in obese than in non-obese OAI participants. 32 Cartilage T2 (relaxation times) are thought to be sensitive to cartilage hydration, collagen content, and tissue anisotropy and thus represent a quantitative mea sure of cartilage composition. 31, 33, 34 Femoro tibial and patellar cartilage T2 were greater in asymptomatic incidence cohort knees that had cartilage and meniscus lesions (as assessed by WORMS) than in those without lesions. 35 Patellar 34 and femoro tibial 36 cartilage T2 were associated with greater physical activity scores and frequent knee-bending activity in participants both with and without risk factors for knee OA. Cartilage T2 was higher 37, 38 and more heterogeneous 38 in knees of individuals with OA risk factors than in those of reference cohort participants, but did not differ between knees with and without ACL tears. 33 Greater cartilage T2 was associated with pain in early OA knees, whereas in knees with morphological abnormalities only cartilage lesions (but not cartilage T2) were associated with pain. 39 A significant increase in T2 over 2 years (P = 0.0072) was reported in the femorotibial (but not femoropatellar) cartilage of reference cohort participants, and was associated with progression of cartilage lesions to higher WORMS grades. 31 By contrast, neither the presence of OA risk factors nor the presence of cartilage lesions at baseline was associated with the 2-year increase in knee cartilage T2. 37 In a 3-year longitudinal study, 40 obese patients with risk factors for knee OA had a higher prevalence of cartilage and meniscus lesions at baseline than healthy reference individuals, and a high BMI was associated with progression of cartilage lesions to higher grades and with an increase in cartilage T2 entropy over 36 months. Furthermore, cartilage T2 at baseline was significantly associated with structural worsening of synovial tissues (cartilage, meniscus, bone marrow) over 3 years. 41 In summary, these data suggest that progression of cartilage and other tissue lesions, and cartilage T2, are associated with physical activity and OA risk factors (such as obesity) and that T2 might have a relation ship with pain and/or structural progression of tissue changes in knee OA.
Meniscus and muscle assessments
Quantitative study of meniscal areas in the healthy reference cohort found ~25% larger tibial plateau and medial meniscus surface areas in men than in women, in knees without meniscus lesions, but the ratio between the two areas, and the tibial plateau coverage by the meniscus (50% medially; 58% laterally) was similar in both sexes. 42 Meniscus surface area was more strongly correlated with (ipsi-compartmental) tibial plateau area than with body height or weight, and physiological medial meniscal extrusion (over the tibia) was somewhat greater in healthy women than in men. 42 A between-knee, within-person comparison revealed less tibial coverage (-5%) and greater meniscus extrusion (+15%) in frequently painful than in contralateral painless knees of identical KLG. 43 In the same sample, significant reductions in quad riceps and vastus medialis muscle anatomical cross-sectional areas (ACSAs) and quadriceps strength were found in painful versus contralateral painless knees, but no differences between painful and painless knees were noted for hamstring and adductor ACSAs, or flexor strength. 44 These findings suggest that meniscus extrusion and lack of quadriceps muscle mass and strength are associated with knee pain. Furthermore, the latter findings suggest that quadriceps strengthening exercise might be useful in treating symptomatic knee OA.
In asymptomatic, middle-aged subjects with risk factors for knee OA, a higher ratio of muscle ACSA between the vastus lateralis and medialis was associated with lower knee cartilage T2 and lower presence and severity of synovial tissue changes (as assessed by WORMS). 2-year rates of change in quadriceps ACSAs and intermuscular fat in the OAI incidence cohort were reported to be similar in participants with and without radiographic OA, indicating that loss of muscle mass and strength occur as a function of ageing rather than being associated with radiographic OA. 45 
Future directions
Prospective, observational studies, such as the OAI, with sufficiently long follow-up to capture slowly-developing OA clinical outcomes are an important resource for biomarker qualification, the evidentiary process that links biomarkers with clinical endpoints and biology. To gain scientific and regulatory acceptance, biomarkers (both prognostic and for measuring efficacy of intervention) must be characterized in multiple studies for their ability to predict and track clinical outcomes, such as pain, disability, and joint surgery. Observational studies of prognostic imaging biomarkers can directly contribute to qualification of such markers, and can identify potential biomarkers for assessing efficacy of interventions in clinical trials.
Efforts are underway using OAI data to identify relationships between baseline and longitudinal imaging biomarkers and pain worsening or other clinical outcomes. A 2012 study, for instance, reported greater denuded areas and greater longitudinal rates of medial femorotibial cartilage thickness loss in a 1-year observational period prior to knee replacement, compared with control knees without knee replacement that were matched for age and KLG. 46 Similar studies focusing on other structural alterations of the diarthrodial joint have been presented at recent conferences. Further efforts are being directed toward defining the need for knee replacement (based on clinical parameters) as a virtual surgical endpoint that can appropriately classify participants who may need, but might be unwilling or unable to undergo, surgery. It is expected that these efforts will identify and appropriately qualify imaging biomarkers within the next 2 years that can be applied in therapeutic trials, to demonstrate usefulness in early decision-making and regulatory approval for showing efficacy of structure-modifying or disease-modifying therapy.
Conclusions
The OAI-involving 4,796 participants with, or at risk for developing, symptomatic knee OA-is an ongoing multi-centre observational cohort study of knee OA jointly sponsored by the NIH and the pharma ceutical industry. It aims to identify sensitive imaging and molecular biomarkers for monitoring the onset and progression of knee OA, and for use in evaluating the effectiveness of disease modifying therapy. Presently clinical, radiographic, and MRI data for baseline, and annual follow-up for 4 years, have been made publicly available to the research community. Publications using the OAI data have examined the precision, sensitivity to change, and corre lation with clinical covariates of imaging outcomes, including radiographic JSW, cartilage thickness, cartilage composition, meniscus morphology, and muscle cross-sectional areas. It is expected that through this qualification process, powerful imaging biomarkers will become available within the next 2 years, which can be applied in therapeutic trials in which the efficacy of disease-modifying or structure-modifying OA drugs are evaluated. a b
Minimal JSW (Duryea et al. 16 ) JSW at xed location with greatest sensitivity to change (Duryea et al. 16 ) Figure 5 | Longitudinal (1-year) loss of cartilage in different regions of the knee (MRI data) and of medial radiographic JSW. The data come from the first release of data by the OAI: a subsample of the OAI progression subcohort (n = 160), stratified by age and sex, and analyses by Hunter et al., 14 Eckstein et al., 15 and Duryea et al. 16 a | Rates of change in cartilage and JSW. b | Sensitivity to change as expressed by the SRM.* Hunter et al. 14 and Duryea et al. 16 examined knees with frequent symptoms and definite radiographic knee OA in 150 participants of this cohort using the sagittal double echo steady state MRI sequence and reported normalized cartilage volume loss (trimmed at joint margins); Eckstein et al. 15 examined 157 right knees of this cohort using the coronal fast low angle shot MRI sequence and reported cartilage thickness loss. SRMs show the same pattern throughout the cartilage plates in both studies, with the femur (cMF) showing greater changes (and sensitivity) than the tibia medially, and the tibia showing greater changes (and sensitivity) than the femur (cLF) laterally. *Mean change divided by the standard deviation of the change. Abbreviations: cLF, lateral weight-bearing (central) femoral condyle; cMF, medial weight-bearing (central) femoral condyle; JSW, joint-space width; OA, osteoarthritis; OAI, OA Initiative; SRM, standardized response mean.
